The expression of CASP-3 was higher in gliomas relative to normal tissues, and it was a risk factor, mainly present in “malignants.” These findings were consistent with the results of Zarnescu et al. and Bodey et al. [47, 48]. Here, CASP3 is linked to central nervous system cancer.